CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 10-Q Report Quarterly Report
- REGDEX Other REGDEX
- ARS Other Annual Report to Security Holders
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- REGDEX Other REGDEX
- 8-K Event Item 5
- 10-K Report Annual Report
- 8-K Event Item 5
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Item 5 · Item 7
- 424B3 Offering Prospectus
- 15-12G Other 15-12G
- S-3/A Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3/A Offering Registration Statement
- 10-Q/A Report 10-Q/A
Page 71 of 77 · 1,525 filings